"10.1371_journal.pone.0084940","plos one","2014-01-31T00:00:00Z","Valli De Re; Laura Caggiari; Mariangela De Zorzi; Renato Talamini; Vito Racanelli; Mario Dâ€™ Andrea; Angela Buonadonna; Vittorina Zagonel; Erika Cecchin; Federico Innocenti; Giuseppe Toffoli","Translational Research, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy; Epidemiology and Biostatistics, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy; Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy; Medical Oncology Unit, San Filippo Neri Hospital, Rome, Italy; Medical Oncology, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy; Medical Oncology, Istituto Oncologico Veneto, IRCCS, Padova, Italy; University of North Carolina, Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America","Performed the experiments: LC MDZ VD. Analyzed the data: VD LC VR FI. Contributed reagents/materials/analysis tools: VD RT EC MDA AB VZ. Wrote the paper: VD LC VR FI GT. Statistical analyses: RT.","Co-author Valli De Re is an Editorial Board member of the PLOS ONE journal. FI receives royalties from the use of the UGT1A1 genetic test. The authors confirm that there are no patents, products in development or marketed products to declare pertinent to this article. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Valli De Re","VDR",11,TRUE,NA,3,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
